Which healthcare AI startups made a close watcher’s top 25 for 2020?

Several healthcare AI companies rank among the “top 25 machine learning startups to watch in 2020” in the view of a senior contributor at Forbes.com.

Louis Columbus, whose day job is principal of the manufacturing software company IQMS, names Olive, Paige and PostEra among his healthcare selections.

Olive’s innovators are “pioneers working to alleviate the most routine, mundane tasks healthcare professionals do on their jobs, so they are freed up to work on more complex, challenging and rewarding treatment programs for their patients,” Columbus writes. He notes that Olive has raised a total of $123.8 million in funding over six rounds.

Paige’s proprietary algorithms “provide insights from decades of data from the world’s experts in cancer care and were recently published in Nature Medicine,” Columbus points out, adding that the company’s first product for prostate cancer detection received Breakthrough Designation from the FDA. Paige has raised a total of $75 million in funding over three rounds, he adds.  

PostEra uses machine learning to close the design-make-test cycle of drug discovery. “They are currently leading an international team of scientists to find a COVID antiviral via an open science initiative,” Columbus reports, adding that the company has raised a total of $2.5 million in funding over two rounds.

Columbus cites Crunchbase stats showing that, across industries, there are more than 9,200 AI startups and established AI concerns relying on machine learning for their main and ancillary applications, products and services—a 6% jump from last year’s count.

To check out the rest of his list, click here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”